Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: A population-based study

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 327-336

  Kulmala, Petri ^a   Savola, Kaisa ^a   Petersen, Jacob S ^b   Vähäsalo, Paula ^a   Karjalainen, Jukka ^a   Löppönen, Tuija ^a   Dyrberg, Thomas ^c   Åkerblom, Hans K ^d   Knip, Mikael ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Glutamic acid decarboxylase; IA 2; Insulin autoantibodies; Insulin dependent diabetes; Islet cell antibodies

Indexed keywords

GLUTAMATE DECARBOXYLASE; IA ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTICLE; CHILD; DISEASE MARKER; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING;

EID: 0032518421     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119879     Document Type: Article

References (47)

1. Cooke, A. 1990. An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr. Top. Microbiol. Immunol. 164:125-142.
2. Castano, L.E., and G.S. Eisenbarth. 1990. Type 1 diabetes: a chronic autoimmune disease of man, mouse and rat. Annu. Rev. Immunol. 8:647-674.
3. Atkinson, M.A., and N.K. Maclaren. 1990. What causes diabetes? Sci. Am. 7:62-67.
4. Gepts, W. 1965. Pathology and anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:619-633.
5. Gorsuch, A.N., K.M. Spencer, J. Lister, J.M. McNally, B.M. Dean, G.F. Bottazzo, and A.C. Cudworth. 1981. Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet. 2:1363-1365.
6. Palmer, J.P. 1993. Predicting IDDM. Use of humoral immune markers. Diabetes Reviews. 1:104-115.
7. Bottazzo, G.F., A. Florin-Christensen, and D. Doniach. 1974. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 2:1279-1282.
8. Lendrum, R., G. Walker, and D.R. Gamble. 1975. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet. 1:880-883.
9. Bonifacio, E., P.J. Bingley, M. Shattock, BM. Dean, D. Dunger, E.A.M. Gale, and G.F. Bottazzo. 1990. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 335:147-149.
10. Riley, W.J., N.K. Maclaren, J. Krischer, R.P. Spillar, J.H. Silverstein, D.A. Schatz, S. Schwartz, J. Malone, S. Shah, C. Vadheim, and J.I. Rotter. 1990. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 323:1167-1172.
11. Palmer, J., P. Clemons, K. Lyen, O. Tatpati, P.K. Raghu, and F.L. Raquette. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1337-1339.
12. Baekkeskov, S., J.H. Nielsen, B. Marner, T. Bilde, J. Ludvigsson, and Å. Lernmark. 1982. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Natuire. 298:167-169.
13. Baekkeskov, S., H.-J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, and P. deCamilli. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:151-156.
14. Baekkeskov, S., M. Landin, J.K. Kristensen, S. Srikanta, G.J. Bruining, T. Mandrup-Poulsen, C. deBeaufort, J.S. Soeldner, G. Eisenbarth, F. Lindgren, et al. 1987. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 79:926-934.
15. r autoantibodies as predictors of insulin-dependent diabetes. Lancet. 335:1357-1360.
16. r 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia. 31:597-602.
17. 65 antibodies in relation to other antibodies and genetic risk markers in children with newly diagnosed IDDM. J. Clin. Endocrinol. Metab. 81:2455-2459.
18. r tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96:1506-1511.
19. Passini, N., J.D. Larigan, S. Genovese, E. Appella, F. Sinigaglia, and L. Rogee. 1995 The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA. 92:9412-9416.
20. Bonifacio, E., V. Lampasona, S. Genovese, M. Ferrari, and E. Bosi. 1995. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155:5419-5426.
21. Bonifacio, E., S. Genovese, S. Braghi, E. Bazzigalupp, V. Lampasona, P.J. Bingley, L. Rosge, M.R. Pastore, E. Bognetti, G.F. Bottazzo, E.M. Gale, and E. Bosi. 1995. Islet autoantibody markers in IDDM: risk assessment strategies yeilding high sensitivity. Diabetologia. 38:816-822.
22. 65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia. 40:95-99.
23. Wiest-Ladenburger, U., R. Hartmann, U. Hartmann, K. Berling, B.O. Bohm and W. Richter. 1997. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes. 46:565-571.
24. Dahlquist, G., I. Blom, G. Holmgren, B. Hagglof, Y. Larsson, G. Sterky, and S. Wall. 1985. The epidemiology of diabetes in Swedish children 0-14 years: a six-year prospective study. Diabetologia. 28:802-808.
25. Veijola, R., H. Reijonen, P. Vähäsalo, E. Sabbah, P. Kulmala, J. Ilonen, H.K. Åkerblom, M. Knip, and the Childhood Diabetes in Finland (DiMe) Study Group. 1996. HLA-DQB1 defined genetic susceptibility, beta-cell autoimmunity and metabolic characteristics in familial and non-familial insulin-dependent diabetes mellitus. J. Clin. Invest. 98:2489-2495.
26. Ziegler, A.G., R. Ziegler, P. Vardi, R.A. Jackson, J.S. Soeldner, and G.S. Eisenbarth. 1989. Life-table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with type I diabetes. Diabetes. 38:1320-1325.
27. Karjalainen, J.K. 1990. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of the disease. Diabetes. 39: 1144-1150.
28. Deschamps, I., C. Boitard, J. Hors, M. Busson, A. Marcelli-Barge, A. Mogenet, and J.-J. Robert. 1992. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study. Diabetologia. 35:951-957.
29. Thivolet, C.H., M. Tappaz, A. Durand, J. Petersen, A. Stefanutti, P. Chatelain, B. Vialettes, W. Scherbaum, and J. Orgiazzi. 1992. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia. 35: 570-576.
30. Krischer, J.P., D. Schatz, W.J. Riley, R.P. Spillar, J.H. Silverstein, S. Schwartz, J. Malone, S. Shah, C.M. Vadheim, J.I. Rotter, et al. 1993. Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: a prospective study in relatives. J. Clin. Endocrinol. Metab. 77:743-749.
31. Schott, M., D. Schatz, M.A. Atkinson, J. Krischer, H. Mehta, B. Vold, and N. Maclaren. 1994. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J. Antoimmunity. 7:865-872.
32. Schmidli, R.S., P.G. Colman, and L.C. Harrison. 1994. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? J. Autoimmunity. 7:873-879.
33. Tuomilehto, J., P. Zimmet, I.R. Mackay, P. Koskela, G. Vidgren, L. Toivanen, E. Tuomilehto-Wolf, K. Kohtamäki, J. Stengård, and M.J. Rowley. 1994. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet. 343:1383-1385.
34. Verge, C.F., R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, R.A. Jackson, H.P. Chase, and G.S. Eisenbarth. 1996. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin. GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 45:926-933.
35. Seissler, J., N.G. Morgenthaler, P. Achenbach, E.F. Lampeter, D. Glawe, M. Payton, M. Christie, W.A. Scherbaum, and the DENIS Study Group. 1996. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia. 39:1351-1356.
36. Tuomilehto, J., R. Lounamaa, E. Tuomilehto-Wolf, A. Reunanen, E. Virtala, E.A. Kaprio, H.K. Åkerblom, and the Childhood Diabetes in Finland Study Group. 1992. Epidemiology of childhood diabetes in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 35:70-76.
37. WHO Study Group. 1985. Diabetes Mellitus. Technical Report Series 727. Geneva:10-12.
38. Greenbaum, C.J., J.P. Palmer, S. Nagataki, Y. Yamaguchi, J.L. Molenaar, W.A.M. VanBeers, N.K. Maclaren, Å. Lernmark, and participating laboratories. 1992. Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes. 41:1570-1574.
39. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:459-467.
40. Schmidli, R.S., P.G. Colman, and E. Bonifacio. 1995. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes. 44:636-640.
41. Schuster, J. 1988. EXACTB and CONF: exact unconditional procedures for binominal data. Am. Stat. 42:234.
42. Kaplan, E., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
43. Mantal, N. 1966. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. 50:163-170.
44. Bingley, P.J., M.R. Christie, E. Bonifacio, R. Bonfanti, M. Shattock, M.-T. Fonte, G.F. Bottazzo, and E.A.M. Gale. 1994. Combined analysis of autoantibodies improves prediction of IDDM in islet cell autoantibody-positive relatives. Diabetes. 43:1304-1310.
45. Roll, U., M.R. Christie, S. Eberhard, and A.-G. Ziegler. 1994. Associations of anti-GAD antibodies with islet cell antibodies in first-degree relatives of tvpe 1 diabetic patients. Diabetes. 43:154-160.
46. Bärmeier, H., D.K. McCulloch, J.L. Neifing, G. Warnock, R.V. Rajotte, J.P. Palmer, and Å. Lernmark. 1991. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia. 34:727-733.
47. Christie, M.R., U. Roll, M.A. Payton, E.C.I. Hatfield, and A.-G. Ziegler. 1997. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care. 20: 965-970.